(Total Views: 163)
Posted On: 04/10/2023 10:39:13 AM
Post# of 25588
$OCLN #BreakingNews CLS Reports Fiscal Third Quarter 2023 Financial Results
LAS VEGAS, NV / ACCESSWIRE / April 10, 2023 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), (the ''Company'' or ''CLS''), a diversified cannabis company operating as Cannabis Life Sciences, today announced its financial results for the fiscal quarter ended February 28, 2023 ("Q3 2023"
. All amounts are expressed in U.S. dollars.
Q3 2023 Financial & Operational Highlights
Net revenue for Q3 2023 was $5,437 million.
Dispensary revenue increased 6% to $ 3,529 million.
Production revenue decreased 15% to $1,908 million.
Gross profit for Q3 2023 was $3,019 million, or 56% of net revenue. Net loss for Q3 2023 was $1,030 million.
EBITDA for Q3 2023 was $505 thousand.
Outlook
A detailed discussion on Q3 2023 results presented by the Chairman and CEO of CLS Holdings USA, Inc., Mr. Andrew Glashow is available on the CLSH website: www.clsholdingsinc.com/ and on the CLSH YouTube channel: https://youtu.be/UgrIxetjX34.
LAS VEGAS, NV / ACCESSWIRE / April 10, 2023 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), (the ''Company'' or ''CLS''), a diversified cannabis company operating as Cannabis Life Sciences, today announced its financial results for the fiscal quarter ended February 28, 2023 ("Q3 2023"
. All amounts are expressed in U.S. dollars. Q3 2023 Financial & Operational Highlights
Net revenue for Q3 2023 was $5,437 million.
Dispensary revenue increased 6% to $ 3,529 million.
Production revenue decreased 15% to $1,908 million.
Gross profit for Q3 2023 was $3,019 million, or 56% of net revenue. Net loss for Q3 2023 was $1,030 million.
EBITDA for Q3 2023 was $505 thousand.
Outlook
A detailed discussion on Q3 2023 results presented by the Chairman and CEO of CLS Holdings USA, Inc., Mr. Andrew Glashow is available on the CLSH website: www.clsholdingsinc.com/ and on the CLSH YouTube channel: https://youtu.be/UgrIxetjX34.
(0)
(0)
